Current Neuropharmacology
Volume 18, 12 Issues, 2020
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
  |
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Neuropharmacology, Volume 12 - Number 4
Editorial
Editorial (Thematic Issue: Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention)
, 12(4): 303 - 307Liang Peng, Vladimir Parpura and Alexei Verkhratsky
DOI: 10.2174/1570159X12999140829152550
Antagonists of the Vasopressin V1 Receptor and of the β1-Adrenoceptor Inhibit Cytotoxic Brain Edema in Stroke by Effects on Astrocytes-but the Mechanisms Differ
, 12(4): 308 - 323Leif Hertz, Junnan Xu, Ye Chen, Marie E. Gibbs and Ting Du
DOI: 10.2174/1570159X12666140828222723
Antagonists of the Vasopressin V1 Receptor and of the β1-Adrenoceptor Inhibit Cytotoxic Brain Edema in Stroke by Effects on Astrocytes-but the Mechanisms Differ
Pathological Role for Exocytotic Glutamate Release from Astrocytes in Hepatic Encephalopathy
, 12(4): 324 - 333Vedrana Montana, Alexei Verkhratsky and Vladimir Parpura
DOI: 10.2174/1570159X12666140903094700
Pathological Role for Exocytotic Glutamate Release from Astrocytes in Hepatic Encephalopathy
Ammonium Activates Ouabain-Activated Signalling Pathway in Astrocytes: Therapeutic Potential of Ouabain Antagonist
, 12(4): 334 - 341Dan Song and Ting Du
DOI: 10.2174/1570159X12666140828222115
Ammonium Activates Ouabain-Activated Signalling Pathway in Astrocytes: Therapeutic Potential of Ouabain Antagonist
Noradrenergic Regulation of Glial Activation: Molecular Mechanisms and Therapeutic Implications
, 12(4): 342 - 352David Braun, Jose L.M. Madrigal and Douglas L. Feinstein
DOI: 10.2174/1570159X12666140828220938
Noradrenergic Regulation of Glial Activation: Molecular Mechanisms and Therapeutic Implications
Calcium-Sensing Receptors of Human Astrocyte-Neuron Teams: Amyloid-β-Driven Mediators and Therapeutic Targets of Alzheimer's Disease
, 12(4): 353 - 364I. Dal Pra, A. Chiarini, R. Pacchiana, E. Gardenal, B. Chakravarthy, J. F. Whitfield and U. Armato
DOI: 10.2174/1570159X12666140828214701
Calcium-Sensing Receptors of Human Astrocyte-Neuron Teams: Amyloid-β-Driven Mediators and Therapeutic Targets of Alzheimer's Disease
Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects
, 12(4): 365 - 379Liang Peng, Li Gu, Baoman Li and Leif Hertz
DOI: 10.2174/1570159X12666140828221720
Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects
Neurodegeneration in Diabetic Retina and Its Potential Drug Targets
, 12(4): 380 - 386Mohammad Shamsul Ola and Abdullah S. Alhomida
DOI: 10.2174/1570159X12666140619205024
Neurodegeneration in Diabetic Retina and Its Potential Drug Targets
Editor-in-Chief
F. Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
University Rome"da Sapienza"
Rome
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
Scopus CiteScore Metrics: 4.72
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net